by Richard Daverman, PhD
December 26, 2013 -- In China, eight young children have died after developing adverse reactions to a hepatitis B vaccine. Six of the newborns were given vaccines produced by Shenzhen Kangtai Biological Products, China’s largest provider of hepatitis B vaccines with a 60% market share. China regulators have stopped all use of Kangtai’s vaccine, pending an investigation. Two other children have died following administration of a vaccine made by Beijing Tiantan Biological Products. So far, authorities have not restricted use of Tiantan’s products. More details....
Help employers find you! Check out all the jobs and post your resume.
